RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials.

Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials.

Add to Collection
2023 Jan RCTs Fist_Author_Year_PM

Full Author : ['Dawed, Adem Y', 'Mari, Andrea', 'Brown, Andrew', 'McDonald, Timothy J', 'Li, Lin', 'Wang, Shuaicheng', 'Hong, Mun-Gwan', 'Sharma, Sapna', 'Robertson, Neil R', 'Mahajan, Anubha', 'Wang, Xuan', 'Walker, Mark', 'Gough, Stephen', "Hart, Leen M 't", 'Zhou, Kaixin', 'Forgie, Ian', 'Ruetten, Hartmut', 'Pavo, Imre', 'Bhatnagar, Pallav', 'Jones, Angus G', 'Pearson, Ewan R']
Journal Title : The lancet. Diabetes & endocrinology
Chapter : Section3
Journal Year : 2023
Cited by : Not Available

BACKGROUND: In the treatment of type 2 diabetes, GLP-1 receptor agonists lower blood glucose concentrations, body weight, and have cardiovascular benefits. The efficacy and side effects of GLP-1 receptor agonists vary between people. Human pharmacogenomic.....

Keywords : ["large randomised control trial", "receptor agonist", "observational datum", "genomewide analysis", "pharmacogenomic"]